HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

In Brief: FDA reform

This article was originally published in The Rose Sheet

Executive Summary

FDA reform: Rep. Scott Klug (R-Wis.), sponsor of the House FDA reform bill on foods (HR 3200), discussed the need to modernize the "zero cancer risk" standard of the Delaney Clause during a May 29 Special Order session on the House floor held by House Commerce/Health Subcommittee Chairman Michael Bilirakis (R-Fla.) and FDA reform sponsors. Referring to a 1995 report by the Human Resources and Intergovernmental Relations Subcommittee, which found that reviewers of food additive petitions "requested too much data that was not even used to determine the safety of a food additive," Klug asserted that the report's findings "support the proposed change in HR 3200 from zero risk to a `negligible risk' standard." Klug also reiterated the need to establish national uniform labeling standards in the interests of maintaining "interstate commerce." The House is expected to begin markup of the bill in the first half of June. In the Senate, the committee report on Sen. Nancy Kassebaum's (R-Kan.) FDA reform bill (S 1477) is expected out the week of June 3...
Advertisement
Advertisement
UsernamePublicRestriction

Register

RS002870

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel